The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

President Trump on Tuesday explained why he revoked former national security adviser John Bolton’s security clearance. “I think there was enough time. We take a job, you take a job ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

The effort to bypass any standard security clearance process would also deprive ... The Trump team initially did not sign a memorandum of understanding that included necessary paperwork to allow ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

Managing Director Nigel Murray said: “Booths really does love Christmas, and this is reflected in our strong performance again this year. Customers trust us to provide the best quality and store ...